)
Edge29 May 2026
Who You Gonna Call? The Story of Rollins
How Rollins built one of America's most consistent businesses through recurring pest control, trusted local brands, and decades of acquisitions.
Neola Medical
Neola Medical (NEOLA) investor relations material
Neola Medical Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary19 May, 2026
Executive summary
Completed enrollment and reported positive safety results from the first clinical pilot study in preterm babies, confirming a favorable safety profile for NeolaⓇ in neonatal intensive care.
Initiated preparations for the next phase of clinical, regulatory, and commercial development, including a planned U.S. clinical study by mid-2027.
Board resolved on a SEK 46.8 million rights issue to fund continued development, supported by existing shareholders and management.
Financial highlights
Operating revenue for Q1 2026 was SEK 2,847k, up from SEK 2,162k in Q1 2025, primarily from capitalized development work.
Operating result was SEK -3,606k, compared to SEK -2,712k in Q1 2025.
Cash flow for the period was SEK -6,168k, with cash and cash equivalents at SEK 9,955k at quarter-end.
Result per share was -0.05 SEK, compared to -0.04 SEK in Q1 2025.
Equity ratio remained strong at 96%.
Outlook and guidance
Focus on advancing NeolaⓇ through further preclinical validation, regulatory interactions, and preparation for a U.S. clinical study.
Planned rights issue expected to provide necessary funding for ongoing development and commercial preparations.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Neola Medical
- Clinical pilot launched, SEK 20M raised, seven patents granted, and equity ratio at 96%.NEOLA
Q4 202512 Feb 2026 - Clinical validation, FDA milestones, and US market entry drive strong financial outlook.NEOLAQ2 20241 Feb 2026
- Advanced to clinical validation, secured patents, and targets U.S. market launch in 2026.NEOLAQ3 202416 Jan 2026
- Advanced to clinical phase with regulatory progress, strong equity, and U.S. market focus.NEOLAQ4 202424 Dec 2025
- U.S. pivotal study site secured, Swedish pilot underway, SEK 20m raised, strong equity and IP.NEOLAQ2 202523 Nov 2025
- Clinical pilot study advances, robust safety data, and SEK 20M raised; U.S. study delayed.NEOLAQ3 20254 Nov 2025
- Q1 2025 saw Neola Medical secure funding, enroll its first clinical patient, and strengthen its IP.NEOLAQ1 20256 Jun 2025
Next Neola Medical earnings date
Q2 202620 Aug, 2026
Neola Medical
Next Neola Medical earnings date
Q2 202620 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage